ReproSource

Executive Summary

ReproSource is a specialized clinical laboratory providing advanced diagnostic testing exclusively for reproductive health. Founded in 2008 and headquartered in Woburn, Massachusetts, the company offers unique fertility diagnostics such as the Ovarian Assessment Report (OAR) and at-home semen analysis collection kits. Its services target fertility specialists, OBGYNs, urologists, and clinical research organizations, aiming to improve reproductive outcomes and support drug development. As a private company with no disclosed fundraising or valuation, ReproSource operates in a niche but growing market driven by increasing infertility rates and demand for personalized fertility care. The company's focus on innovation and client services positions it well within the reproductive diagnostics sector, though its lack of public financial data and stage information limits visibility. With a specialized portfolio and a clear value proposition, ReproSource is poised to capitalize on the expanding fertility diagnostics market, particularly as awareness of reproductive health grows and more couples seek assisted reproductive technologies.

Upcoming Catalysts (preview)

• Q4 2026Launch of Next-Generation Ovarian Assessment Test60% success
• H1 2027Strategic Partnership with a Major Fertility Clinic Network50% success
• Q2 2027FDA Clearance for a Novel At-Home Diagnostic Kit40% success